As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Infertility Drugs Market: By Drug Class: Gonadotrophins, Aromatase Inhibitors, Selective Estrogen Receptor Modulators (SERMs), Biguanides, Others; By End User; by Distribution Channel; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Infertility Drugs Market Outlook

The global infertility drugs market is expected to grow at a CAGR of 6.20% in the forecast period of 2022-2027.

 

The Gonadotrophins Segment Based on Drug Class Holds a Significant Share in the Global Infertility Drugs Industry

The gonadotrophins segment based on drug class accounts for a significant share in the market owing to the ability of gonadotrophins to ameliorate the chances of women being pregnant. A single gonadotrophin injection can stimulate the ovaries of women to produce follicles, which contain egg.

 

Global Infertility Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

In addition to this, women are becoming more aware about reduced side-effects associated with gonadotrophins. Hence, the segment accounts for a significant share in the market and is expected to witness a considerable growth in the coming years.

 

North America Accounts for a Significant Share in the Market

According to a research study, there is an increase in the number of  couples in North America and Europe who are trying to conceive and are facing the risk of infertility . This is mainly due to the hectic and busy lifestyles  of people in countries like the United States and Canada. In some of the states in the US, insurance policies also cover the costs of infertility treatment. This is driving the growth of the infertility drugs industry in North America. In addition to this, the thriving pharmaceutical industry in the region, coupled with highly trained doctors in hospitals and clinics, is one of the key factors driving the market growth in the region.

 

Infertility Drugs: Industry Definition and Segmentation

Infertility drugs are drugs that are used to boost fertility among men and women who have difficulty getting pregnant. Infertility drugs are usually prescribed by doctors to stimulate ovulation in women and promote the production of healthy sperm among men.

Based on drug class, the market can be segmented into:

  • Gonadotrophins
  • Aromatase Inhibitors
  • Selective Estrogen Receptor Modulators (SERMs)
  • Biguanides
  • Others

The significant end users of the product include:

  • Male
  • Female

The segmentation of the market, on the basis of distribution channel, is as follows:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Rising Cases of Infertility among Men and Women to Boost the Growth of the Infertility Drugs Industry

The global infertility drugs industry is driven by the rising cases of infertility globally, or difficulty carrying a pregnancy to term. Certain medical conditions among men and women,  such as diabetes, cystic fibrosis, testicular failure, hormonal disorders, menopausal disorders, urinary infections, endometriosis, pelvic inflammatory disease (PID), and ovarian cysts, among others, can lead to infertility. The surge in the cases of these disorders can be attributed to unhealthy lifestyles and changing dietary habits, including smoking, anabolic steroid use, stress, obesity, and others, thereby contributing to the demand for infertility drugs . In addition, the market is anticipated to be supported by the development of advanced infertility treatment laboratories in emerging economies owing to the increased healthcare expenditure by the governments. This is expected to aid the market in the forecast period.

 

Key Industry Players in the Global Infertility Drugs Market

The report gives a detailed analysis of the following key players in the global infertility drugs market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Merck KGaA
  • Abbott Laboratories
  • Mankind Pharma
  • Pfizer Inc.
  • Ferring Pharmaceuticals Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter’s five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Drug Class, End User, Distribution Channel, Region
Breakup by Drug Class Gonadotrophins, Aromatase Inhibitors, Selective Estrogen Receptor Modulators (SERMs), Biguanides, Others
Breakup by End User Male, Female
Breakup by Distribution Channel Hospital Pharmacies, Retail Pharmacies, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Merck KGaA, Abbott Laboratories, Mankind Pharma, Pfizer Inc., Ferring Pharmaceuticals Inc., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Infertility Drugs Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Infertility Drugs Historical Market (2017-2021) 
    8.3    Global Infertility Drugs Market Forecast (2022-2027)
    8.4    Global Infertility Drugs Market by Drug Class
        8.4.1    Gonadotrophins
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Aromatase Inhibitors
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Selective Estrogen Receptor Modulators (SERMs)
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Biguanides
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2017-2021)
            8.4.4.3    Forecast Trend (2022-2027)
        8.4.5    Others
    8.5    Global Infertility Drugs Market by End User
        8.5.1    Male
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Female
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
    8.6    Global Infertility Drugs Market by Distribution Channel
        8.6.1    Hospital Pharmacies
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Retail Pharmacies
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Others
    8.7    Global Infertility Drugs Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Merck KGaA
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Abbott Laboratories
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Mankind Pharma
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Pfizer Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Ferring Pharmaceuticals Inc.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments

 

Additional Customisations Available

1    Manufacturing Process
    1.1    Overview
    1.2    Detailed Process Flow
    1.3    Operation Involved
2    Project Requirement and Cost Analysis
    2.1    Land, Location and Site Development
    2.2    Construction
    2.3    Plant Machinery
    2.4    Cost of Raw Material
    2.5    Packaging
    2.6    Transportation
    2.7    Utilities
    2.8    Manpower
    2.9    Other Capital Investment

 

List of Figures and Tables

1.    Global Infertility Drugs Market: Key Industry Highlights, 2017 and 2027
2.    Global Infertility Drugs Historical Market: Breakup by Drug Class (USD Million), 2017-2021
3.    Global Infertility Drugs Market Forecast: Breakup by Drug Class (USD Million), 2022-2027
4.    Global Infertility Drugs Historical Market: Breakup by End-User (USD Million), 2017-2021
5.    Global Infertility Drugs Market Forecast: Breakup by End-User (USD Million), 2022-2027
6.    Global Infertility Drugs Historical Market: Breakup by Distribution Channel (USD Million), 2017-2021
7.    Global Infertility Drugs Market Forecast: Breakup by Distribution Channel (USD Million), 2022-2027
8.    Global Infertility Drugs Historical Market: Breakup by Region (USD Million), 2017-2021
9.    Global Infertility Drugs Market Forecast: Breakup by Region (USD Million), 2022-2027
10.    North America Infertility Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
11.    North America Infertility Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Europe Infertility Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Europe Infertility Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Asia Pacific Infertility Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Asia Pacific Infertility Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Latin America Infertility Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Latin America Infertility Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Middle East and Africa Infertility Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
19.    Middle East and Africa Infertility Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
20.    Global Infertility Drugs Market Structure

Key Questions Answered in the Report

The market is estimated to grow at a CAGR of 6.20% between 2022 and 2027.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major drivers of the industry, such as the rising cases of infertility among men and women, improving healthcare facilities, growing awareness, and the establishment of advanced infertility treatment laboratories, are expected to aid the market growth.

The key market trends guiding the growth of the industry include the growing FDA approval of new and efficient infertility drugs.

Gonadotrophins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), and biguanides, among others are the different segments based on drug class.

Male and female are the different end users considered within the market report.

Hospital pharmacies and retail pharmacies, among others are the different distribution channels of infertility drugs.

The major players in the industry are Merck KGaA, Abbott Laboratories, Mankind Pharma, Pfizer Inc., and Ferring Pharmaceuticals Inc., among others.

Analyst Review

The global infertility drugs market is being driven by the rising cases of infertility among men and women. Aided by the rising investments to develop advanced infertility treatment laboratories, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 6.20%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on drug class, the market is divided into gonadotrophins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), and biguanides, among others. On the basis of end user, the market is divided into male and female. The major distribution channels of the product are hospital pharmacies and retail pharmacies, among others. The major regional markets for infertility drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Merck KGaA, Abbott Laboratories, Mankind Pharma, Pfizer Inc., and Ferring Pharmaceuticals Inc., among others. 

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER